![Sachiyo Minegishi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sachiyo Minegishi
Operationeel Directeur bij
Rectify Pharmaceuticals LLC
Profiel
Sachiyo Minegishi is currently Chief Operating Officer at Rectify Pharmaceuticals LLC since 2023.
Former positions include Independent Director at Mural Oncology Plc from 2024 to 2025, Vice President at bluebird bio, Inc. from 2016 to 2020, Senior Director-US Cardiology Rare Disease at Aegerion Pharmaceuticals, Inc. from 2012 to 2016, and Chief Financial Officer at Akouos, Inc. Education includes an undergraduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.
Actieve functies van Sachiyo Minegishi
| Bedrijven | Functie | Begin |
|---|---|---|
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Operationeel Directeur | 01-04-2023 |
Eerdere bekende functies van Sachiyo Minegishi
| Bedrijven | Functie | Einde |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2020 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-04-2016 |
| AKOUOS | Financieel Directeur/CFO | - |
Opleiding van Sachiyo Minegishi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Health Technology |
